SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-18-001546
Filing Date
2018-02-28
Accepted
2018-02-28 16:01:17
Documents
58
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_022818.htm 10-K 686805
2 EXHIBIT 23.1 exh_231.htm EX-23.1 2684
3 EXHIBIT 31.1 exh_311.htm EX-31.1 7173
4 EXHIBIT 31.2 exh_312.htm EX-31.2 7581
5 EXHIBIT 32.1 exh_321.htm EX-32.1 4647
  Complete submission text file 0001171843-18-001546.txt   3701771

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE caps-20171231.xml EX-101.INS 530987
7 XBRL SCHEMA FILE caps-20171231.xsd EX-101.SCH 38855
8 XBRL CALCULATION FILE caps-20171231_cal.xml EX-101.CAL 32959
9 XBRL DEFINITION FILE caps-20171231_def.xml EX-101.DEF 266306
10 XBRL LABEL FILE caps-20171231_lab.xml EX-101.LAB 283829
11 XBRL PRESENTATION FILE caps-20171231_pre.xml EX-101.PRE 304613
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21214 | Film No.: 18651031
SIC: 2834 Pharmaceutical Preparations